To investigate the antiangiogenetic mechanism of stellettin B, we detected the protein expression of HIF-1α, p-Stat3, and the downstream angiogenesis effector, VEGF, which was inhibited by stellettin B treatment in glioblastoma cell lines (Figure 6). This evidence concerns the gene HIF1A and glioblastoma.